Efficacy and safety of apremilast in patients with mild to moderate plaque psoriasis: Results of a phase 3, multicenter, randomized, double-blind, placebo-controlled trial
Journal of the American Academy of Dermatology | Aug 06, 2021
Improvement in hidradenitis suppurativa and quality of life in patients treated with adalimumab: Real‐world results from the HARMONY study
Journal of the European Academy of Dermatology and Venereology | Aug 04, 2021
Comorbid obesity and history of diabetes are independently associated with poorer treatment response to biologics at 6 months: a prospective analysis in corrona psoriasis registry
Journal of the American Academy of Dermatology | Jul 30, 2021